Screenpoint Medical B.V.
Explore this company’s associated devices, FDA decisions and regulatory history.

Screenpoint Medical B.V.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Screenpoint Medical B.V.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Aug 14, 2026 to Aug 14, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QDQ appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: Mercator Ii, 7th Floor, Toernooiveld 300, Nijmegen, 6525 EC, NL. Recorded on K260898, decision dated Aug 14, 2026.
Device categories in this collection
Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Transpara (2.1.0)K260898 | Screenpoint Medical B.V. | 510(k) clearance | Aug 14, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.
